Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity

Journal of Epidemiology and Community Health

Volumn 61, Issue 7, 2007, Pages 631-637

  Gilbody, Simon ^a   Lightfoot, Tracy ^a   Sheldon, Trevor ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

COHORT ANALYSIS; HETEROGENEITY; MENTAL HEALTH; META-ANALYSIS; RISK FACTOR; VITAMIN;

ARTICLE; CONFIDENCE INTERVAL; DATA ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; FOLIC ACID DEFICIENCY; HEALTH SURVEY; HUMAN; OBSERVATIONAL STUDY; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW;

DEPRESSION; FOLIC ACID; GREAT BRITAIN; HUMANS;

EID: 34347267644     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.2006.050385     Document Type: Article

References (59)

1. Murray CJ, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from disease, injuries and risk factors in 1990. Boston, MA: Harvard School of Public Health on behalf of the World Bank, 1996.
2. Singleton N, Bumpstead R, O'Brien M, et al. Office of National Statistics: psychiatric morbidity among adults living in private households, 2000. London: Her Majesty's Stationery Office, 2001.
3. Carney MWP. Serum folate values in 423 psychiatric patients. BMJ 1967;4:512-16.
4. Reynolds EH, Preece JM, Bailey J, et al. Folate deficiency in depressive illness. Br J Psychiatry 1970;117:287-92.
5. Taylor MJ, Carney S, Geddes J, et al. Folate for depressive disorders. Cochrane Database Syst Rev 2003;(2):CD003390.
6. Cantoni GL. S-anenysylmethionine: a new intermediate formed enzymatically from 1-methionine ana adenosine triphosphate. J Biol Chem 1953;204:403-16.
7. Reynolds EH, Carney MWP. Methylation and mood. Lancet 1984;28:196-8.
8. Lucock M. Is folic acid the ultimate functional food component for disease prevention? BMJ 2004;328:211-14.
9. Jacques PF, Selhub J, Bostom AG, et al. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449-54.
10. Hickling S, Hung J, Knuiman M, et al. Impact of voluntary folate fortification on plasma homocysteine and serum folate in Australia from 1995 to 2001: a population based cohort study. J Epidemiol Community Health 2005;59:371-6.
11. Short R. UK government consults public on compulsory folate fortification. BMJ 2006;332:873-a.
12. World Health Organisation. International Statistical Classification of Diseases and Related Health Problems - 10th Revision. Geneva: WHO, 1990.
13. Coppen A, Bolander-Gouaille C. Treatment of depression: time to consider folic acid and vitamin B12. Jl Psychopharmacol 2005;19:59-65.
14. Bottiglieri T. Homocysteine and folate metabolism in depression. Prog Neuro- Psychopharmacol Biol Psychiatry 2005;29:1103-12.
15. Petitti DB. Meta analysis, decision analysis and cost effectiveness analysis. Oxford: Oxford University Press, 2000.
16. Berlin JA. Invited commentary. Am J Epidemiol 1995;142:383-7.
17. Sutton AJ, Abrams KR, Jones DR, et al. Systematic reviews of trials and other studies. Health Technol Assess 1999;2:1-276.
18. Egger M, Davey Smith G, Schneider M. Systematic reviews of observational studies. In: Egger M, Davey Smith G, Altman DG, eds. Systematic reviews in health care. London: BMJ Books, 2000:211-27.
19. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) Group. J Am Med Assoc 2000;283:2008-12.
20. Pettiti DB. Coronary heart disease and estrogen replacement therapy. Can compliance bias explain the results of observational studies? Ann Epidemiol 1994;4:115-18.
21. Ford ES, Smith SJ, Stroup DF, et al. Homocysteine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int Jo Epidemiol 2002;31:59-70.
22. NHS Centre for Reviews and Dissemination. Undertaking systematic reviews of research on effectiveness: CRD report 4, 2nd edn. York: University of York, 2001.
23. Churchill R, Hunot V, McGuire H. Cochrane Depression Anxiety and Neurosis Group. In:Cochrane Library.Issue 2. Oxford: Update Software, 2004.
24. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
25. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
26. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 1999;18:2693-708.
27. Higgins JPT, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med 2004;23:1663-82.
28. Egger M, Davey-Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
29. Lindeman RD, Romero LJ, Koehler KM, et al. Serum vitamin B12, C and folate concentrations in the New Mexico Elder Health Survey: correlations with cognitive and affective functions. J Am Coll Nutr 2000;19:68-76.
30. Tolmunen T, Voutilainen S, Hintikka J, et al. Dietary folate and depressive symptoms are associated in middle-aged Finnish men. J Nutr 2003;133:3233-6.
31. Tiemeier H, van Tuijl HR, Hofman A, et al. Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Am J Psychiatry 2002;159:2099-101.
32. Penninx BW, Guralnik JM, Ferrucci L, et al. Vitamin B(12) deficiency and depression in physically disabled older women: epidemiologic evidence from the Women's Health and Aging Study. Am J Psychiatry 2000;157:715-21.
33. Bjelland I, Tell GS, Vollset SE, et al. Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch Gen Psychiatry 2003;60:618-26.
34. Morris MS, Fava M, Jacques PF, et al. Depression and folate status in the US Population. Psychother Psychosom 2003;72:80-7.
35. Ramos MI, Allen LH, Haan MN, et al. Plasma folate concentrations are associated with depressive symptoms in elderly Latina women despite folic acid fortification. Am J Clin Nutr 2004;80:1024-8.
36. Kasper JD, Shapiro S, Guralnik JM, et al. Designing a community study of moderately to severely disabled older women: the Women's Health and Ageing Study. Ann Epidemiol 1999;9:498-507.
37. Carney MW, Chary TK, Laundy M, et al. Red cell folate concentrations in psychiatric patients. J Affect Disord 1990;19:207-13.
38. Lee S, Wing YK, Fong S. A controlled study of folate levels in Chinese inpatients with major depression in Hong Kong. J Affect Disord 1998;49:73-7.
39. Abou-Saleh MT, Coppen A. Serum and red blood cell folate in depression. Acta Psychiatr Scand 1989;80:78-82.
40. Tolmunen T, Hintikka J, Ruusunen A, et al. Dietary folate and the risk of depression in Finnish middle-aged men. A prospective follow-up study. PsychotherPsychosom 2004;73:334-9
41. American Psychiatric Association. Diagnostic and Statistical Manual-4th edition. Washington DC: American Psychiatric Association, 1994.
42. Ghadirian AM, Ananth J, Engelsmann F. Folic acid deficiency and depression. Psychosomatics 1980;21:926-9.
43. Chen CS, Tsai JC, Tsang HY, et al. Homocysteine levels, MTHFR C677T genotype, and MRI hyperintensities in late-onset major depressive disorder. Am J Geriatr Psychiatry 2005;13:869-75.
44. Knapp S, Irwin M. Plasma levels of tetrahydrobiopterin and folate in major depression. Biol Psychiatry 1989;26:156-62.
45. Rosche J, Uhlmann C, Froscher W. Low serum folate levels as a risk factor for depressive mood in patients with chronic epilepsy. J Neuropsychiatr Clin Neurosci 2003;15:64-6.
46. Wilkinson AM, Anderson DN, Abou-Saleh MT, et al. 5-Methyltetrahydrofolate level in the serum of depressed subjects and its relationship to the outcome of ECT. J Affect Disord 1994;32:163-8.
47. Lerner V, Kanevsky M, Dwolatzky T, et al. Vitamin B(12) and folate serum levels in newly admitted psychiatric patients. Clin Nutr 2005;25:60-7.
48. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.
49. Rothman K, Greenland S. Causation and causal inference. In: Rothman K, Greenland S, eds. Modern epidemiology. New York: Lippincott-Raven, 1998:7-29.
50. Thompson S. Why sources of heterogeneity in meta-analysis should be invetsigated. In: Chalmers I, Altman DG, eds. Systematic reviews. London: BMJ, 1995.
51. Lewis SJ, Lawlor DA, Davey Smith G, et al. The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a meta-analysis. Mol Psychiatry 2006;11:352-60.
52. Gilbody S, Lewis S, Lighfoot T. MTHFR polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol 2007;165:1- 13.
53. Kelly CB, McDonnell AP, Johnston TG, et al. The MTHFR C677T polymorphism is associated with depressive episodes in patients from Northern Ireland. J Psychopharmacol 2004;18:567-71.
54. Tan EC, Chong SA, Lim LC, et al. Genetic analysis of the thermolabile methylenetetrahydrofolate reductase variant in schizophrenia and mood disorders. Psychiatr Genet 2004;14:227-31.
55. Almeida OP, Flicker L, Lautenschlager NT, et al. Contribution of the MTHFR gene to the causal pathway for depression, anxiety and cognitive impairment in Tater life. Neurobiol Aging 2005;26:251- 7.
56. Davey Smith G, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1-22.
57. Davey Smith G, Ebrahim S. What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ 2005;330:1076-9.
58. Taylor MJ, Carney S, Geddes J, et al. Folate for depressive disorders (Cochrane Review). In:The Cochrane Library.Issue 3. Chichester: John Wiley & Sons, 2004.
59. Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord 2000;60:121-30.